Only a few years ago the benefits of lateral flow diagnostic tests weren’t widely understood outside of scientific circles. The reason most people came into contact with the technology was through the ...

Lateral flow tests remain in high demand with many people across Merseyside saying they've found the kits hard to get hold of. Back in December, key workers and the public were unable to get PCR and ...

High demand for lateral flow tests has resulted in supply issues, with many people unable to get their hands on the kits in recent days and pharmacies warning of “huge problems” with kit deliveries.

The United Kingdom government plans to implement mass scale population testing for SARS-CoV-2 infection using Lateral Flow Devices (LFDs), yet the devices' sensitivity is unknown. A study published in ...

Scientists and public health experts built the COVID-19 pandemic response on years of experience navigating infectious disease outbreaks. Although lateral flow immunoassays have been central to ...

When the coronavirus pandemic first took hold, trying to get a COVID test was like trying to get Glastonbury tickets. Hard to come by is an understatement. But now, well over a year on, a key part of ...

HENDERSON, Nev., July 8, 2025 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, today announces it has demonstrated quantification of ...

During the early stages of the coronavirus disease 2019 (COVID-19), rapid testing was imperative for public health policymakers and health care workers in order to determine where and what measures ...

Throughout the Covid pandemic, UK residents were able to get packs of lateral flow tests for free via the NHS but since the 1st of April 2022 that hasn't been the case for people living in England.

Free packs of rapid lateral flow tests can be posted to people’s homes or collected at several places across the country. The tests involve rubbing a swab over the tonsils and inside the nose, much ...

CAMBRIDGE & WETHERBY, England--(BUSINESS WIRE)--Avacta Group plc (AIM: AVCT), a clinical stage biopharmaceutical company developing innovative cancer therapies and powerful diagnostics based on its ...